Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Summary

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).

Timeline

Start

2024-10-01

Primary completion

2027-05-31

Completion

2027-05-31

Publications

• Fensterwald M, Johnson J, Moreno A, Conger-Love S, Flippen C, Hesterman C, Johnston M, Kamins J, Minota K, Pak P, Hashim S, Huynh-Tran TL, Kobayashi N, Shane B, Charles A, Nwaobi S. Suzetrigine as a novel treatment for headache disorders: A case series. Headache. 2026 Jul-Aug;66(7):1644-1649. doi: 10.1111/head.70147. Epub 2026 Jun 5.

Drugs

Indications